Genmab ADR (NASDAQ: GMAB) is -4.50% lower on its value in year-to-date trading and has touched a low of $17.24 and a high of $30.41 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The GMAB stock was last observed hovering at around $19.36 in the last trading session, with the day’s gains setting it 0.57%.
Currently trading at $19.93, the stock is -1.89% and -1.61% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.6 million and changing 2.94% at the moment leaves the stock -11.41% off its SMA200. GMAB registered -30.80% loss for a year compared to 6-month loss of -10.75%.
The stock witnessed a 10.66% gain in the last 1 month and extending the period to 3 months gives it a 6.63%, and is -7.52% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.34% over the week and 2.24% over the month.
Genmab ADR (GMAB) has around 2682 employees, a market worth around $12.25B and $3.23B in sales. Current P/E ratio is 11.30 and Fwd P/E is 11.17. Profit margin for the company is 35.11%. Distance from 52-week low is 15.64% and -34.46% from its 52-week high. The company has generated returns on investments over the last 12 months (20.91%).
The EPS is expected to shrink by -10.33% this year.
Genmab ADR (GMAB) Top Institutional Holders
The shares outstanding are 635.50M, and float is at 614.73M with Short Float at 0.39%.
The top institutional shareholder in the company is ALLIANCEBERNSTEIN L.P. with over 15.24 million shares valued at $382.93 million. The investor’s holdings represent 23.4845% of the GMAB Shares outstanding. As of 2024-06-30, the second largest holder is BLACKROCK INC. with 5.08 million shares valued at $127.67 million to account for 7.8301 of the shares outstanding. The other top investors are CAPITAL INTERNATIONAL INVESTORS which holds 4.23 million shares representing 6.5161% and valued at over $108.15 million, while HARDING LOEVNER LP holds 4.2657 of the shares totaling 2.77 million with a market value of $69.61 million.
Genmab ADR (GMAB) Insider Activity
#####
